The Weight-Loss Pill Has Arrived: What Orforglipron (Foundayo) Means for Ireland

Orforglipron (Foundayo) is the first GLP-1 weight-loss pill, no needle, approved in the US in 2026. What the ATTAIN-1 clinical trial shows, how the tablet compares to Ozempic and Wegovy, and when the weight-loss pill will reach Ireland. A pharmacist’s guide from Laois Pharmacy.

Continue ReadingThe Weight-Loss Pill Has Arrived: What Orforglipron (Foundayo) Means for Ireland

Retatrutide: The ‘Triple G’ Weight-Loss Injection Explained, and When Ireland Might See It

Retatrutide has produced up to 25% weight loss in Phase 3 trials, the strongest yet. What the TRIUMPH clinical trials actually show, how it compares to Ozempic and Mounjaro, and the honest timeline for when it will be available in Ireland. A pharmacist’s guide.

Continue ReadingRetatrutide: The ‘Triple G’ Weight-Loss Injection Explained, and When Ireland Might See It

Ozempic vs Wegovy vs Mounjaro: What’s the Difference? An Irish Pharmacist Explains

Ozempic and Wegovy are the same medicine at different doses, here’s the full comparison table, Mounjaro included, with Irish prices, who each suits, and the GP-first route to getting started. From Laois Pharmacy, Portlaoise.

Continue ReadingOzempic vs Wegovy vs Mounjaro: What’s the Difference? An Irish Pharmacist Explains